D. O'connor

发表

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Nguyen H. Tran, Kathryn Jones, Tao Dong, 2020, The Lancet.

Gene expression profiling reveals insights into infant immunological and febrile responses to group B meningococcal vaccine

A. Pollard, M. Sadarangani, Ushma Galal, 2020, Molecular systems biology.

Genetic material should be routinely collected in clinical vaccine trials--high consent rates can be achieved across all age groups.

J. Trück, A. Pollard, M. Snape, 2013, Vaccine.

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2020, Lancet.

Host genetic variants near the PAX5 gene locus associate with susceptibility to invasive group A streptococcal disease

A. Hill, J. Knight, K. Elliott, 2019 .

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Calliope A. Dendrou, I. Pavord, J. Todd, 2021, Cell.

The omics strategy: the use of systems vaccinology to characterize immune responses to childhood immunization

D. O'connor, D. O’Connor, 2022, Expert review of vaccines.

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery.

R. Rappuoli, S. Davis, M. Pizza, 2000, Vaccine.

Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19

Calliope A. Dendrou, I. Pavord, G. Rodger, 2022, The Lancet Digital Health.

Immunogenicity and Reactogenicity of a Reduced Schedule of a 4-component Capsular Group B Meningococcal Vaccine: A Randomized Controlled Trial in Infants.

A. Pollard, Ushma Galal, M. Snape, 2020, Open forum infectious diseases.

Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials

Nguyen H. Tran, Vidyashankara G. Iyer, Andreas C. Themistocleous, 2021, The Lancet.

Viral vector vaccines

A. Pollard, T. Lambe, D. O'connor, 2022, Current Opinion in Immunology.

The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age.

T. Odrljin, D. Kelly, G. Blanchard-Rohner, 2013, Vaccine.

Seroprevalence and Placental Transmission of Maternal Antibodies Specific for Neisseria meningitidis Serogroups A, C, Y and W135 and Influence of Maternal Antibodies on the Immune Response to a Primary Course of MenACWY-CRM Vaccine in the United Kingdom

D. Kelly, K. Ford, G. Blanchard-Rohner, 2013, The Pediatric infectious disease journal.

Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection

J. Knight, V. Libri, A. Mentzer, 2022, Nature Medicine.

Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of Infants.

D. Bonsall, T. Heikkinen, C. Giaquinto, 2020, The Journal of infectious diseases.

Effects of technical noise on bulk RNA-seq differential gene expression inference

A. Pollard, I. Mohorianu, D. O'connor, 2019, bioRxiv.

Identification of novel locus associated with coronary artery aneurysms and validation of loci for susceptibility to Kawasaki disease

C. Hoggart, Jihoon Kim, V. Wright, 2021, European Journal of Human Genetics.

Distinct patterns of within-host virus populations between two subgroups of human respiratory syncytial virus

D. Bonsall, P. Beutels, T. Heikkinen, 2021, Nature Communications.

Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine.

A. Pollard, A. Hill, M. Snape, 2014, Vaccine.

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.

Nguyen H. Tran, Andreas C. Themistocleous, David J. Smith, 2020, Lancet.

Searching for the human genetic factors standing in the way of universally effective vaccines

A. Mentzer, A. Pollard, A. Hill, 2015, Philosophical Transactions of the Royal Society B: Biological Sciences.

Common Genetic Variations Associated with the Persistence of Immunity following Childhood Immunization.

C. Hoggart, C. Khor, M. Hibberd, 2019, Cell reports.

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Nguyen H. Tran, Andreas C. Themistocleous, P. Klenerman, 2020, Nature Medicine.

The Clinical Application of MicroRNAs in Infectious Disease

A. Pollard, R. Drury, D. O'connor, 2017, Front. Immunol..

Distinct patterns of whole blood transcriptional responses are induced in mice following immunisation with adenoviral and poxviral vector vaccines encoding the same antigen

A. Pollard, C. Dold, D. O'connor, 2021, BMC genomics.

The effect of chronic cytomegalovirus infection on pneumococcal vaccine responses.

J. Trück, A. Pollard, M. Voysey, 2014, The Journal of infectious diseases.

Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Nguyen H. Tran, Andreas C. Themistocleous, P. Klenerman, 2020, Nature Medicine.

Characterizing vaccine responses using host genomic and transcriptomic analysis.

A. Pollard, D. O'connor, D. O’Connor, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine

D. Kelly, A. Pollard, M. Snape, 2017, Genome Medicine.

Changes in epigenetic profiles throughout early childhood and their relationship to the response to pneumococcal vaccination

A. Salas, B. Fairfax, J. Trück, 2021, Clinical epigenetics.

The effect of H1N1 vaccination on serum miRNA expression in children: A tale of caution for microRNA microarray studies

A. Pollard, R. Drury, D. O'connor, 2019, PloS one.

RNA2HLA: HLA-based quality control of RNA-seq datasets

Andrew J. Pollard, Irina Chelysheva, Daniel O'connor, 2021, Briefings Bioinform..

Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses

Nguyen H. Tran, Andreas C. Themistocleous, M. Wand, 2021, Nature Medicine.

Transcriptomic response and immunological responses to chimpanzee adenovirus- and MVA viral-vectored vaccines for RSV in healthy adults

P. Klenerman, L. Silva-Reyes, C. Dold, 2023, Clinical and experimental immunology.

A naturally protective epitope of limited variability as an influenza vaccine target

O. Pybus, Sunetra Gupta, D. Palmer, 2018, Nature Communications.

An epitope of limited variability as a novel influenza vaccine target

O. Pybus, Sunetra Gupta, D. Palmer, 2017, bioRxiv.